Adeno-associated viral vector-encoding vascular endothelial growth factor gene: Effect on cardiovascular MR perfusion and infarct resorption measurements in swine

Radiology

Volumn 243, Issue 2, 2007, Pages 451-460

  Saeed, Maythem ^a   Saloner, David ^a   Martin, Alastair ^a   Do, Loi ^a   Weber, Oliver ^a   Ursell, Philip C ^a   Jacquier, Alexis ^a   Lee, Randall ^b   Higgins, Charles B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; GADOTERATE MEGLUMINE; HEMATOXYLIN; HYPOXIA INDUCIBLE FACTOR 1; ISOLECTIN; LECTIN; PARVOVIRUS VECTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOTINYLATION; BRAIN INFARCTION SIZE; CARDIOVASCULAR PERFORMANCE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DENSITY; GENE EXPRESSION; GENETIC CODE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STUDENT T TEST; SWINE;

ADENOVIRIDAE; ANIMALS; GENETIC VECTORS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION; SWINE; TRANSFECTION; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34247532746     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2432060928     Document Type: Article

References (53)

1. Tirziu D, Simons M. Angiogenesis in the hitman heart: gene and cell therapy. Angiogenesis 2005;8:241-251.
2. Kreedman SB, Inser JM. Therapeutic angiogenesis for coronary artery disease. Ann Intern Med 2002;136:54-71.
3. Henry TD, Annex BH, McKendall GR, et al. The VIVA Trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 2003;107:1359-1365.
4. Barbash IM, Chouraqui P, Baron J, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infracted myocardium. Circulation 2003;108:863-868.
5. Berns KI, Linden RM. Site-specific Integration by adeno-associated virus. Proc Natl Acad Sci U S A 1996;93:11288-11294.
6. Davidson BL, Stein CS, Heth JA, et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors; transduction of variant cell tvpes and regions in the mammalian central nervous system. Proc Natl Acad Sci U S A 2000;97:3428-3432.
7. Fisher KJ, Jooss K, Alston J, et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med 1997;3:306-312.
8. Herzog RW. AAV-mediated gene transfer to skeletal muscle. Methods Mol Biol 2004;246: 179-194.
9. Su H, Lu R, Kan YW. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Proc Natl Acad Sci U S A 2000;97:13801-13806.
10. Su H, Joho S, Huang Y, et al. Adeno-associated viral vector delivers cardiac specific and hypoxia-inducible VEGF expression in ischemic mouse heart. Proc Natl Acad Sci U S A 2004;101:16280-16285.
11. Saeed M, Wendland MF, Sakuma H, et al. Coronary artery stenosis: detection with contrast, enhanced MR imaging in dogs. Radiology 1995;196:79-84.
12. Saeed M, Weber O, Lee R, et al. Discrimination of myocardial acute and chronic (scar) infarctions on delayed contrast enhanced magnetic resonance imaging with intravascular magnetic resonance contrast media. J Am Coll Cardiol 2006;48:1961-1968.
13. Lund GK, Stork A, Saeed M, et al. Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201TI SPECT imaging. Radiology 2004;232:49-57.
14. Semelka RC, Tomei E, Wagner S, et al. Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle. Am Heart J 1990;119:1367-1373.
15. Wagner A, Mahrholdt H, Thomson L, et al. Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delaved contrast enhancement. J Am Coll Cardiol 2006;47(10):2027-2033.
16. Zhao JL, Yang YJ, You SJ, et al. Pretreatment with fosinopril or valsartan reduces myocardial no-reflow after acute myocardial infarction and reperfusion. Coron Artery Dis 2006;17(5):463-469.
17. Linke A, Muller P, Nurzynska D, et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A 2005; 102(25):8966-8971.
18. Saeed M, Wendland MF, Szolar D, et al. Quantification of the extent of area at risk with fast contrast-enhanced magnetic resonance imaging in experimental coronary artery stenosis. Am Heart J 1996;132:921-932.
19. Saeed M, Lee RJ, Weber O, et al. Scarred myocardium imposes additional burden on remote viable myocardium despite a reduction in the extent, of area with late contrast MR enhancement. Eur Radiol 2006;16:827-836.
20. Theilmeier G, Verhamme P, Dymarkowski S, et al. Hypercholesterolemia in mini-pigs impairs left ventricular response to stress: association with decreased coronary flow reserve and reduced capillary density. Circulation 2002;106:1140-1146.
21. Fuchs S, Dib N, Cohen BM, et al. A randomized, double-blind, placebo-controlled, multicenter, pilot, study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease. Catheter Cardiovasc Interv 2006;68(3):372-378.
22. Losordo DW, Vale PR, Hendel RC, et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 2002; 105(17):2012-2018.
23. Kastrnp J, Jorgensen E, Ruck A, et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris: a randomized double-blind placebo-controlled study - the Euroinject One trial. Enroinject One Group. J Am Coll Cardiol 2005;45(7): 982-988.
24. Biswas SS, Hughes GC, Scarborough JE, et al. Intramyocardial and intracoronary basic fibroblast growth factor in porcine hibernating myocardium: a comparative study. J Thorac Cardiovasc Surg 2004;127(1):34-43.
25. Pearlrnan JD, Laham RJ, Simons M. Coronary angiogenesis: detection in vivo with MR imaging sensitive to collateral neocirculation - preliminary study in pigs. Radiology 2000;214(3):801-807.
26. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau H. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000;102: 898-901.
27. Huszthy PC, Svendsen A, Wilson JM, et al. Widespread dispersion of adeno-associated virus serotype 1 and adeno-associated virus serotype 6 vectors in the rat central nervous system and in human multiforme xenografts. Hum Gene Ther 2005;10:381-392.
28. Smith-Arica JR, Bartlett JS. Gene therapy: recombinant adeno-associated virus vectors. Curr Cardiol Rep 2001;3:43-49.
29. Isner JM. Myocardial gene therapy. Nature 2002;415:234-239.
30. Goncalves MA. Adeno-associate virus: from defective virus to effective vector. Virol J 2005;2:43-79.
31. Rissanen IT, Korpisalo P, Markkanen JE, et al. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis. Circulation 2003;112:3937-3946.
32. Zimmerman SD, Criscione J, Covell JW. Remodeling in myocardium adjacent to an infarction in the pig left ventricle. Am J Physiol Heart Circ Physiol 2004;287:H2697-H2704.
33. Hong H, Aksenov S, Guan X, Fallon JT, Waters D, Chen C. Remodeling of small intramyocardial coronary arteries distal to a severe epicardial coronary artery stenosis. Arterioscler Thromb Vasc Biol 2002;22(12): 2059-2065.
34. Kocher O, Gabbiani G. Expression of actin mRNAs in rat aortic smooth muscle cells during development, experimental intimal thickening, and culture. Differentiation 1986; 32:245-251.
35. Gabbiani G, Kocher O, Bloom WS, Vandekerckhove J, Weber K. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J Clin Invest 1984;73(1):148-152.
36. Canty JM Jr, Judd RM, Brody AS, Klocke FJ. First-pass entry of nonionic contrast agent into the myocardial extravascnlar space: effects on radiographic estimates of transit time and blood volume. Circulation 1991; 84(5):2071-2078.
37. Rissanen TT, Rutanen J, Yla-Herttuala S. Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemia. Adv Genet 2004;52:117-164.
38. Kocher AA, Schuster MD, Szaholcs MJ, et al. Neovascularization of ischemic myocardium by human hone marrow-derived angioblasts prevents cardioniyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430-436.
39. Fieno DS, Hillenbrand HB, Rehwald WG, et al. Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size. J Am Coll Cardiol 2004;43: 2124-2131.
40. Richard V, Murry CF, Reimer KA. Healing of myocardial infarcts in dogs: effects of late reperfusion. Circulation 1995;92:1891-1901.
41. Laguens R, Caheza Meckert P, Vera Janavel G, et al. Entrance in mitosis of adult cardiomyocytes in ischemic pig hearts after AAV-mediated rhVEGF 165 geno transfer. Gene Ther 2002;9:1676-1681.
42. Laguens R, Cabeza Meckert P, Vera Janavel G, et al. Cardiomyocyte hyperplasia after AAV-VEGF mediated vascular endothelial growth factor gene transfer in pigs with chronic myocardial ischemia. J Gene Med 2004;6:222-227.
43. Battegay EJ. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 1995;73:333-346.
44. Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 2005; 26:549-557.
45. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE. Gadolinium delayed enhanoement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004;43:2253-2259.
46. Hughes GC, Post MJ, Simons M, Annex BH. Porcine models of human coronary artery: implications for preclinical trials of therapeutic angiogenesis. J Appl Physiol 2003;94: 1689-1701.
47. Choi CJ, Haji-Momenian S, Dimaria JM, et, al. Infarct involution and improved function during healing of acute myocardial infarction: the role of microvascular obstruction. J Cardiovasc Magn Reson 2004;6:917-925.
48. Hill JM, Dick AJ, Raman VK, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003;108:1009-1014.
49. Kraitchmnn DL, Heldman AW, Atalar E, et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003;107:2290-2293.
50. Saeed M, Saloner D, Weber O, Martin A, Henk C, Higgins C. MRI in guiding and assessing intramyocardial therapy. Eur Radiol 2005;15:851-863.
51. Aicher A, Brenner W, Zuhayra M, et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003;107:2134-2139.
52. Hou D, Youssef EA, Brinton TJ, et, al. Radiolabeled cell distribution after intramyocardial, intracoronary and interstitial retrograde coronary venous delivery. Circulation 2005;112(9 suppl):I150-I156.
53. Ferrarini M, Arsic N, Recchia FA, et al. Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs. Circ Res 2006;98(7):954-961.